Pedro C. Lara

3.2k total citations
107 papers, 2.0k citations indexed

About

Pedro C. Lara is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Pedro C. Lara has authored 107 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Oncology, 36 papers in Radiology, Nuclear Medicine and Imaging and 32 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Pedro C. Lara's work include Effects of Radiation Exposure (19 papers), Advanced Radiotherapy Techniques (15 papers) and Cancer Immunotherapy and Biomarkers (10 papers). Pedro C. Lara is often cited by papers focused on Effects of Radiation Exposure (19 papers), Advanced Radiotherapy Techniques (15 papers) and Cancer Immunotherapy and Biomarkers (10 papers). Pedro C. Lara collaborates with scholars based in Spain, United States and Italy. Pedro C. Lara's co-authors include M. Lloret, Luis Alberto Henríquez‐Hernández, Elisa Bordón, Carlos Rodríguez‐Gallego, Agustín Sánchez Rey, Meritxell Arenas, S. Sabater, Albert Biete, Julián Panés and Víctor Hernández and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nature Immunology and PLoS ONE.

In The Last Decade

Pedro C. Lara

96 papers receiving 2.0k citations

Peers

Pedro C. Lara

ONCOL

RNMI

PRM

Xin Yang China

Mitoshi Akiyama Japan

Richard S. Stubbs New Zealand

Daniel S. Higginson United States

Hideki Fuse Japan

Yoichiro Kusunoki Japan

Seishi Kyoizumi Japan

D. van Beuningen Germany

Marc E. Martignoni Germany

Joseph Kaminski United States

Xin Yang China

Pedro C. Lara

407 ×0.6

ONCOL

645 ×1.1

279 ×0.6

RNMI

424 ×0.9

PRM

345 ×1.0

Citations per year, relative to Pedro C. Lara Pedro C. Lara (= 1×) peers Xin Yang

Countries citing papers authored by Pedro C. Lara

Since Specialization

Citations

This map shows the geographic impact of Pedro C. Lara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pedro C. Lara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pedro C. Lara more than expected).

Fields of papers citing papers by Pedro C. Lara

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pedro C. Lara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pedro C. Lara. The network helps show where Pedro C. Lara may publish in the future.

Co-authorship network of co-authors of Pedro C. Lara

This figure shows the co-authorship network connecting the top 25 collaborators of Pedro C. Lara. A scholar is included among the top collaborators of Pedro C. Lara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pedro C. Lara. Pedro C. Lara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

McNulty, J.P., Adrian P. Brady, Boris Brkljačić, et al.. (2025). Guidelines and recommendations for radiographer education from the EU-REST project. Insights into Imaging. 16(1). 242–242.

Lara, Pedro C., et al.. (2025). Artificial intelligence in dysphagia assessment: evaluating lingual muscle composition in head and neck cancer. Clinical & Translational Oncology. 27(9). 3717–3731.

Tubin, S., Marie‐Catherine Vozenin, Yolanda Prezado, et al.. (2023). Novel unconventional radiotherapy techniques: Current status and future perspectives – Report from the 2nd international radiation oncology online seminar. Clinical and Translational Radiation Oncology. 40. 100605–100605. 21 indexed citations

Calabrese, Edward J., Walter J. Kozumbo, Rachna Kapoor, et al.. (2021). Nrf2 activation putatively mediates clinical benefits of low-dose radiotherapy in COVID-19 pneumonia and acute respiratory distress syndrome (ARDS): Novel mechanistic considerations. Radiotherapy and Oncology. 160. 125–131. 30 indexed citations

Lara, Pedro C., et al.. (2020). Same pollution sources for climate change might be hyperactivating the NLRP3 inflammasome and exacerbating neuroinflammation and SARS mortality. Medical Hypotheses. 146. 110396–110396. 8 indexed citations

Pérez-Beteta, Julián, David Molina-García, Carlos Velásquez, et al.. (2019). Morphologic Features on MR Imaging Classify Multifocal Glioblastomas in Different Prognostic Groups. American Journal of Neuroradiology. 40(4). 634–640. 12 indexed citations

Lloret, M., et al.. (2019). Feasibility of a deep hyperthermia and radiotherapy programme for advanced tumors: first Spanish experience. Clinical & Translational Oncology. 21(12). 1771–1775. 2 indexed citations

Lara, Pedro C., et al.. (2018). Radioterapia intraoperatoria con Intrabeam® para el tratamiento del adenocarcinoma de páncreas resecable. Cirugía Española. 96(8). 482–487. 3 indexed citations

Rodríguez-Ruiz, María E., Inmaculada Rodríguez, Fernando López‐Campos, et al.. (2018). Immune mechanisms mediating abscopal effects in radioimmunotherapy. Pharmacology & Therapeutics. 196. 195–203. 55 indexed citations

10.

Sologuren, Ithaisa, Carlos Rodríguez‐Gallego, & Pedro C. Lara. (2014). Immune effects of high dose radiation treatment: implications of ionizing radiation on the development of bystander and abscopal effects. Translational Cancer Research. 3(1). 18–31. 42 indexed citations

11.

Lara, Pedro C., Jesús J. López‐Peñalver, Virgínea Farias, et al.. (2013). Direct and bystander radiation effects: A biophysical model and clinical perspectives. Cancer Letters. 356(1). 5–16. 26 indexed citations

12.

Guedea, Ferrán, et al.. (2013). Challenges of Radiation Oncology in Spain Today. Reports of Practical Oncology & Radiotherapy. 18(6). 401–404.

13.

Lara, Pedro C., et al.. (2011). IGF-1R expression predicts clinical outcome in patients with locally advanced oral squamous cell carcinoma. Oral Oncology. 47(7). 615–619. 33 indexed citations

14.

Bordón, Elisa, Luis Alberto Henríquez‐Hernández, Pedro C. Lara, et al.. (2010). Prediction of clinical toxicity in locally advanced head and neck cancer patients by radio-induced apoptosis in peripheral blood lymphocytes (PBLs). Radiation Oncology. 5(1). 4–4. 33 indexed citations

15.

Zumbado, Manuel, Octavio P. Luzardo, Pedro C. Lara, et al.. (2009). Insulin-like growth factor-I (IGF-I) serum concentrations in healthy children and adolescents: Relationship to level of contamination by DDT-derivative pesticides. Growth Hormone & IGF Research. 20(1). 63–67. 28 indexed citations

16.

Henríquez‐Hernández, Luis Alberto, Pedro C. Lara, Elisa Bordón, et al.. (2009). Constitutive gene expression profile segregates toxicity in locally advanced breast cancer patients treated with high-dose hyperfractionated radical radiotherapy. Radiation Oncology. 4(1). 17–17. 28 indexed citations

17.

Lara, Pedro C., M. Lloret, Bernardino Clavo, et al.. (2009). Severe hypoxia induces chemo-resistance in clinical cervical tumors through MVP over-expression. Radiation Oncology. 4(1). 29–29. 34 indexed citations

18.

Lloret, M., Pedro C. Lara, Elisa Bordón, et al.. (2007). IGF-1R expression in localized cervical carcinoma patients treated by radiochemotherapy. Gynecologic Oncology. 106(1). 8–11. 24 indexed citations

19.

Lara, Pedro C., et al.. (1998). Tumor proliferation, p53 expression, and apoptosis in laryngeal carcinoma. Cancer. 83(12). 2493–2501. 35 indexed citations

20.

Lara, Pedro C., et al.. (1998). The role of Ki67 proliferation assessment in predicting local control in bladder cancer patients treated by radical radiation therapy. Radiotherapy and Oncology. 49(2). 163–167. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact